Research graph
References from Metastatic Bone Disease Is Associated With Longitudinal Muscle Loss and Reduced Survival in Kidney Cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Orphan Disease Status of Cancer Cachexia in the USA and in the European Union: A Systematic Review
10.1002/jcsm.12402 · 2019 · External reference
Inter‐Tissue Communication in Cancer Cachexia
10.1038/s41574-018-0123-0 · 2018 · External reference
Understanding Cachexia in the Context of Metastatic Progression
10.1038/s41568-020-0251-4 · 2020 · External reference
Ponsegromab for the Treatment of Cancer Cachexia
10.1056/nejmoa2409515 · 2024 · External reference
Incidence of Patients With Bone Metastases at Diagnosis of Solid Tumors in Adults: A Large Population‐Based Study
10.21037/atm.2020.03.55 · 2020 · External reference
The Bone Microenvironment Invigorates Metastatic Seeds for Further Dissemination
10.1016/j.cell.2021.03.011 · 2021 · External reference
Excess TGF‐beta Mediates Muscle Weakness Associated With Bone Metastases in Mice
10.1038/nm.3961 · 2015 · External reference
Choosing the Right Cell Line for Renal Cell cancer Research
10.1186/s12943-016-0565-8 · 2016 · External reference
The Combination of Low Skeletal Muscle Mass and High Tumor Interleukin‐6 Associates With Decreased Survival in Clear Cell Renal Cell Carcinoma
10.3390/cancers12061605 · 2020 · External reference
Cancer Statistics, 2024
2024 · External reference
The Impact of Non‐Bone Metastatic Cancer on Musculoskeletal Health
10.1007/s11914-024-00872-4 · 2024 · External reference
Prognosis of Renal Cell Carcinoma With Bone Metastases: Experience From a Large Cancer Centre
10.1016/j.ejca.2018.10.023 · 2019 · External reference
New Players in the Landscape of Renal Cell Carcinoma Bone Metastasis and Therapeutic Opportunities
10.1002/ijc.35181 · 2025 · External reference
Muscle Matters: Skeletal Muscle Index and Body Mass Index Impact on Complications and Survival in Renal Cancer
10.1002/bco2.405 · 2024 · External reference
Radiodensities of Skeletal Muscle and Visceral Adipose Tissues Are Prognostic Factors in Clear‐Cell Renal Cell Carcinoma
10.1158/1055-9965.epi-24-0306 · 2024 · External reference
Associations Between Pretreatment Body Composition Features and Clinical Outcomes Among Patients With Metastatic Clear Cell Renal Cell Carcinoma Treated With Immune Checkpoint Blockade
10.1158/1078-0432.ccr-22-1389 · 2022 · External reference
Prognostic Significance of Sarcopenia in Patients With Metastatic Renal Cell Carcinoma
10.1016/j.juro.2015.08.071 · 2016 · External reference
Early Skeletal Muscle Loss During Target Therapy Is a Prognostic Biomarker in Metastatic Renal Cell Carcinoma Patients
10.1038/s41598-017-07955-6 · 2017 · External reference
Cancer‐Associated Cachexia: Bridging Clinical Findings With Mechanistic Insights in Human Studies
10.1158/2159-8290.cd-25-0293 · 2025 · External reference
Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First‐Line Ipilimumab Plus Nivolumab
10.1016/j.clgc.2023.05.006 · 2023 · External reference
Early Changes in Volumetric Body Composition Parameters Predict Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy
10.3390/jcm14093140 · 2025 · External reference
Body Composition and Lung cancer‐Associated cachexia in TRACERx
10.1038/s41591-023-02232-8 · 2023 · External reference
Structured Exercise After Adjuvant Chemotherapy for Colon Cancer
10.1056/nejmoa2502760 · 2025 · External reference
Ethical Guidelines for Publishing in the Journal of Cachexia, Sarcopenia and Muscle: Update 2021
10.1002/jcsm.12899 · 2021 · External reference
